The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.

about

The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.

Item

http://www.wikidata.org/entity/Q47642907

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The effectiveness and safety o ...... ventions: A systematic review.

@en

The effectiveness and safety o ...... ventions: A systematic review.

@nl

type

Item

label

The effectiveness and safety o ...... ventions: A systematic review.

@en

The effectiveness and safety o ...... ventions: A systematic review.

@nl

prefLabel

The effectiveness and safety o ...... ventions: A systematic review.

@en

The effectiveness and safety o ...... ventions: A systematic review.

@nl

P1476

The effectiveness and safety o ...... ventions: A systematic review.

@en

P2093

Jamal Ait Ichou

http://www.w3.org/2001/XMLSchema#string

Karine Suissa

http://www.w3.org/2001/XMLSchema#string

Mark J Eisenberg

http://www.w3.org/2001/XMLSchema#string

Natasha Larivée

http://www.w3.org/2001/XMLSchema#string

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Left ventricular support by catheter-mounted axial flow pump reduces infarct size.

The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters

The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention

Intra-aortic balloon counterpulsation for the treatment of myocardial infarction complicated by acute severe heart failure.

Use of the Impella 2.5 in high-risk percutaneous coronary intervention.

A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

P304

1250-1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.27316

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kristian B Filion

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28941078

http://www.w3.org/2001/XMLSchema#string